Companies Dominating the Microbiome Therapeutics Landscape
- YSOPIA Bioscience
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- 4D pharma plc
- Enterome
- BiomX Inc.
- Ferring International Center S.A.
- Vedanta Biosciences, Inc.
- Seres Therapeutics, Inc.
- Assembly Biosciences, Inc.
- Synlogic
- Finch Therapeutics Group, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
2025 Microbiome Therapeutics Market is estimated at USD 631.69 million.
The global microbiome therapeutics market size was valued at over USD 531.37 million in 2024 and is projected to grow at a robust CAGR of 23.6%, surpassing USD 8.35 billion by 2037.
North America is likely to reach USD 3.34 billion by 2037, attributed to advanced research facilities, increasing healthcare spending, and awareness.
The major players in the market include YSOPIA Bioscience, 4D pharma plc, Enterome, BiomX Inc., Ferring International Center S.A., Vedanta Biosciences, Inc., Seres Therapeutics, Inc., Assembly Biosciences, Inc., Synlogic, Finch Therapeutics Group, Inc.
